ASSESSMENT OF HYPERTRIGLYCERIDEMIA ASSOCIATED RESIDUAL CARDIOVASCULAR RISK IN SECONDARY PREVENTION PATIENTS

被引:0
|
作者
Gungor, B. [1 ]
Simsek, B. [1 ]
Cinar, T. [2 ]
Inan, D. [3 ]
Genc, D. [3 ]
Yumurtas, A. [1 ]
Vatanoglu, E. [4 ]
Yuksel, G. [5 ]
Karabay, C. [1 ]
机构
[1] Univ Hlth Sci Dr Siyami Ersek Hosp, Cardiol, Istanbul, Turkiye
[2] Haydarpasa Sultan Abdulhamid Han Training & Res H, Cardiol, Istanbul, Turkiye
[3] Basak Basaksehir Cam & Sakura City Hosp, Cardiol, Istanbul, Turkiye
[4] Karadeniz Eregli State Hosp, Cardiol, Zonguldak, Turkiye
[5] Artvin State Hosp, Cardiol, Artvin, Turkiye
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P443
引用
收藏
页码:S144 / S144
页数:1
相关论文
共 50 条
  • [21] Hypertriglyceridemia and cardiovascular risk
    Demnati, C.
    Fendi, O.
    Trimeche, A.
    Hajji, R.
    Trabelsi, N.
    Ben Mami, F.
    Dakhli, S.
    Achour, A.
    DIABETES & METABOLISM, 2010, 36 : A96 - A96
  • [22] Primary and secondary cardiovascular prevention results in patients with stroke: relapse risk and associated survival (Ebrictus study)
    Clua-Espuny, Josep Ll
    Pinol-Mores, Josep Ll
    Gil-Guillen, Vicente F.
    Orozco-Beltran, Domingo
    Panisello-Tafalla, Anna
    Lucas-Noll, Jorgina
    Lluissa Queralt-Tomas, M.
    Pla-Farnos, Roger
    REVISTA DE NEUROLOGIA, 2012, 54 (02) : 81 - 92
  • [23] Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers
    Garcia-Rayado, Guillermo
    Sostres, Carlos
    Lanas, Angel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 875 - 888
  • [24] TARGETED PROTEOMICS IMPROVES CARDIOVASCULAR RISK PREDICTION IN SECONDARY PREVENTION PATIENTS
    Nurmohamed, Nick S.
    Pereira, Joao P. Belo
    Hoogeveen, Renate M.
    Kroon, Jeffrey
    Kraaijenhof, Jordan M.
    Waissi, Farahnaz
    Timmerman, Nathalie
    Bom, Michiel
    Hoefer, Imo
    Knaapen, Paul
    Catapano, Alberico L.
    Koenig, Wolfgang
    de Kleijn, Dominique
    Visseren, Frank
    Levin, Evgeni
    Stroes, Erik S. G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 957 - 957
  • [25] Risk factors in cardiovascular patients: Challenges and opportunities to improve secondary prevention
    Gabulova, Rahima
    Marza-Florensa, Anna
    Rahimov, Uzeyir
    Isayeva, Mahluga
    Alasgarli, Shahana
    Musayeva, Afag
    Gahramanova, Sona
    Ibrahimov, Firdovsi
    Aliyev, Farid
    Imanov, Galib
    Rasulova, Rahmana
    Vaartjes, Ilonca
    Klipstein-Grobusch, Kerstin
    Graham, Ian
    Grobbee, Diederick E.
    WORLD JOURNAL OF CARDIOLOGY, 2023, 15 (07): : 342 - 353
  • [26] "Actua" project: secondary prevention in patients at high-cardiovascular risk
    Prieto Lobato, A.
    Corbi Pascual, M. J.
    Redondo Prieto, M.
    Cubells Pastor, M.
    Muros Ortega, A.
    Carrasco Carrasco, E.
    Cordoba Soriano, J. G.
    Martinez Pastor, A.
    Division Garrote, J. A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2550 - 2550
  • [27] LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins
    Wei, Wei-Qi
    Li, Xiaohui
    Feng, Qiping
    Kubo, Michiaki
    Kullo, Iftikhar J.
    Peissig, Peggy L.
    Karlson, Elizabeth W.
    Jarvik, Gail P.
    Lee, Ming Ta Michael
    Shang, Ning
    Larson, Eric A.
    Edwards, Todd
    Shaffer, Christian M.
    Mosley, Jonathan D.
    Maeda, Shiro
    Horikoshi, Momoko
    Ritchie, Marylyn
    Williams, Marc S.
    Larson, Eric B.
    Crosslin, David R.
    Bland, Sarah T.
    Pacheco, Jennifer A.
    Rasmussen-Torvik, Laura J.
    Cronkite, David
    Hripcsak, George
    Cox, Nancy J.
    Wilke, Russell A.
    Stein, C. Michael
    Rotter, Jerome I.
    Momozawa, Yukihide
    Roden, Dan M.
    Krauss, Ronald M.
    Denny, Joshua C.
    CIRCULATION, 2018, 138 (17) : 1839 - 1849
  • [28] PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers
    Duffy, Danielle
    Rooney, Bridget
    Adams, Suzanne
    Whellan, David J.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (11) : 1251 - 1260
  • [29] Secondary prevention program:: Impact on cardiovascular risk
    Plaza, Ignacio
    Garcia, Sara
    Madero, Rosario
    Zapata, Maria A.
    Perea, Jesus
    Sobrino, Jose A.
    Lopez-Sendon, Jose L.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (02): : 205 - 208
  • [30] Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
    Robson, J.
    HEART, 2008, 94 (10) : 1331 - 1332